S T Fitzgerald1,2, Y Liu3, D Dai3, O M Mereuta3,2,4, M Abbasi3, J L A Larco5, A S Douglas2,4, D F Kallmes3, L Savastano5, K M Doyle2,4, W Brinjikji3,5. 1. From the Departments of Radiology (S.T.F., Y.L., D.D., O.M.M., M.A., D.F.K., W.B.) Sean.Fitzgerald@nuigalway.ie. 2. Department of Physiology (S.T.F., O.M.M., A.S.D., K.M.D.). 3. From the Departments of Radiology (S.T.F., Y.L., D.D., O.M.M., M.A., D.F.K., W.B.). 4. SFI Centre for Research in Medical Devices (O.M.M., A.S.D., K.M.D.), National University of Ireland Galway, Galway, Ireland. 5. Neurosurgery (J.L.A.L., L.S., W.B.), Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND AND PURPOSE: Previous studies have successfully created blood clot analogs for in vitro endovascular device testing using animal blood of various species. Blood components vary greatly among species; therefore, creating clot analogs from human blood is likely a more accurate representation of thrombi formed in the human vasculature. MATERIALS AND METHODS: Following approval from the Mayo Clinic institutional review board, human whole-blood and platelet donations were obtained from the blood transfusion service. Twelve clot analogs were created by combining different ratios of red blood cells + buffy coat, plasma, and platelets. Thrombin and calcium chloride were added to stimulate coagulation. Clot composition was assessed using histologic and immunohistochemical staining. To assess the similarities of mechanical properties to patient clots, 3 types of clot analogs (soft, elastic, and stiff) were selected for in vitro thrombectomy testing. RESULTS: The range of histopathologic compositions produced is representative of clots removed during thrombectomy procedures. The red blood cell composition ranged from 8.9% to 91.4%, and fibrin composition ranged from 3.1% to 53.4%. Platelets (CD42b) and von Willebrand Factor ranged from 0.5% to 47.1% and 1.0% to 63.4%, respectively. The soft clots had the highest first-pass effect and successful revascularization rates followed by the elastic and stiff clots. Distal embolization events were observed when clot ingestion could not be achieved, requiring device pullback. The incidence rate of distal embolization was the highest for the stiff clots due to the weak clot/device integration. CONCLUSIONS: Red blood cell-rich, fibrin-rich, and platelet-rich clot analogs that mimic clots retrieved from patients with acute ischemic stroke were created in vitro. Differing retrieval outcomes were confirmed using in vitro thrombectomy testing in a subset of clots.
BACKGROUND AND PURPOSE: Previous studies have successfully created blood clot analogs for in vitro endovascular device testing using animal blood of various species. Blood components vary greatly among species; therefore, creating clot analogs from human blood is likely a more accurate representation of thrombi formed in the human vasculature. MATERIALS AND METHODS: Following approval from the Mayo Clinic institutional review board, human whole-blood and platelet donations were obtained from the blood transfusion service. Twelve clot analogs were created by combining different ratios of red blood cells + buffy coat, plasma, and platelets. Thrombin and calcium chloride were added to stimulate coagulation. Clot composition was assessed using histologic and immunohistochemical staining. To assess the similarities of mechanical properties to patient clots, 3 types of clot analogs (soft, elastic, and stiff) were selected for in vitro thrombectomy testing. RESULTS: The range of histopathologic compositions produced is representative of clots removed during thrombectomy procedures. The red blood cell composition ranged from 8.9% to 91.4%, and fibrin composition ranged from 3.1% to 53.4%. Platelets (CD42b) and von Willebrand Factor ranged from 0.5% to 47.1% and 1.0% to 63.4%, respectively. The soft clots had the highest first-pass effect and successful revascularization rates followed by the elastic and stiff clots. Distal embolization events were observed when clot ingestion could not be achieved, requiring device pullback. The incidence rate of distal embolization was the highest for the stiff clots due to the weak clot/device integration. CONCLUSIONS: Red blood cell-rich, fibrin-rich, and platelet-rich clot analogs that mimic clots retrieved from patients with acute ischemic stroke were created in vitro. Differing retrieval outcomes were confirmed using in vitro thrombectomy testing in a subset of clots.
Authors: Daniel Gebrezgiabhier; Yang Liu; Adithya S Reddy; Evan Davis; Yihao Zheng; Albert J Shih; Aditya S Pandey; Luis E Savastano Journal: J Neurosurg Date: 2021-01-22 Impact factor: 5.115
Authors: B Gory; D Bresson; I Kessler; M L Perrin; A Guillaudeau; K Durand; S Ponsonnard; C Couquet; C Yardin; C Mounayer Journal: AJNR Am J Neuroradiol Date: 2013-03-28 Impact factor: 3.825
Authors: Yang Liu; Yihao Zheng; Adithya S Reddy; Daniel Gebrezgiabhier; Evan Davis; Joshua Cockrum; Joseph J Gemmete; Neeraj Chaudhary; Julius M Griauzde; Aditya S Pandey; Albert J Shih; Luis E Savastano Journal: J Neurosurg Date: 2020-02-28 Impact factor: 5.115
Authors: David S Liebeskind; Nerses Sanossian; William H Yong; Sidney Starkman; Michael P Tsang; Antonio L Moya; David D Zheng; Anna M Abolian; Doojin Kim; Latisha K Ali; Samir H Shah; Amytis Towfighi; Bruce Ovbiagele; Chelsea S Kidwell; Satoshi Tateshima; Reza Jahan; Gary R Duckwiler; Fernando Viñuela; Noriko Salamon; J Pablo Villablanca; Harry V Vinters; Victor J Marder; Jeffrey L Saver Journal: Stroke Date: 2011-03-10 Impact factor: 7.914
Authors: Osama O Zaidat; Alicia C Castonguay; Italo Linfante; Rishi Gupta; Coleman O Martin; William E Holloway; Nils Mueller-Kronast; Joey D English; Guilherme Dabus; Tim W Malisch; Franklin A Marden; Hormozd Bozorgchami; Andrew Xavier; Ansaar T Rai; Michael T Froehler; Aamir Badruddin; Thanh N Nguyen; M Asif Taqi; Michael G Abraham; Albert J Yoo; Vallabh Janardhan; Hashem Shaltoni; Roberta Novakovic; Alex Abou-Chebl; Peng R Chen; Gavin W Britz; Chung-Huan J Sun; Vibhav Bansal; Ritesh Kaushal; Ashish Nanda; Raul G Nogueira Journal: Stroke Date: 2018-02-19 Impact factor: 7.914
Authors: Christian Maegerlein; Benjamin Friedrich; Maria Berndt; Kristin Elizabeth Lucia; Lucas Schirmer; Holger Poppert; Claus Zimmer; Jaroslav Pelisek; Tobias Boeckh-Behrens; Johannes Kaesmacher Journal: Interv Neuroradiol Date: 2017-10-23 Impact factor: 1.610
Authors: Hsiao-Chuan Liu; Mehdi Abbasi; Yong Hong Ding; Eric C Polley; Seán Fitzgerald; Ramanathan Kadirvel; David F Kallmes; Waleed Brinjikji; Matthew W Urban Journal: J Biophotonics Date: 2020-12-17 Impact factor: 3.207
Authors: Kajo van der Marel; Ju-Yu Chueh; Olivia W Brooks; Robert M King; Miklos G Marosfoi; Erin T Langan; Sarena L Carniato; Matthew J Gounis; Raul G Nogueira; Ajit S Puri Journal: J Neurointerv Surg Date: 2016-02-01 Impact factor: 5.836
Authors: Daniela Dumitriu LaGrange; Vincent Braunersreuther; Isabel Wanke; Jatta Berberat; Siri Luthman; Seán Fitzgerald; Karen M Doyle; Olivier Brina; Philippe Reymond; Alexandra Platon; Michel Muster; Paolo Machi; Pierre-Alexandre Poletti; Maria Isabel Vargas; Karl-Olof Lövblad Journal: Front Neurol Date: 2022-03-07 Impact factor: 4.003